| Authors: |
Sahebkar A; Halal Research Center of IRI, FDA, Tehran, Iran. saheb2000@yahoo.com.; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. saheb2000@yahoo.com.; Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. saheb2000@yahoo.com.; School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. saheb2000@yahoo.com., Simental-Mendía LE; Biomedical Research Unit, Mexican Social Security Institute, Durango, Mexico., Pirro M; Unit of Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Medicine, University of Perugia, Perugia, Italy., Banach M; Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113, Lodz, Poland.; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland., Watts GF; School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia.; Lipid Disorders Clinic, Cardiometabolic Services, Department of Cardiology, Royal Perth Hospital, GPO Box, X2213, Perth, Australia., Sirtori C; Centro Dislipidemie, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy., Al-Rasadi K; Department of Clinical Biochemistry, Sultan Qaboos University Hospital, Muscat, Oman., Atkin SL; Weill Cornell Medicine Qatar, Doha, Qatar. sla2002@qatar-med.cornell.edu. |